Clinical trial
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
NCT06439654 is registered in ClinicalTrials.gov with Atlantic Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
- Lead sponsor
- Atlantic Health System
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2024
- Completion date
- December 31, 2027
- Enrollment
- 250 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
apolipoprotein b 100, familial defective, familial hypercholesterolemia, high density lipoprotein deficiency, lipoprotein types--lp system lp(a) hyperlipoproteinemia, low-density-lipoid-type hyperlipoproteinemia